Altimmune inc (ALT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALT Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Altimmune inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent63.01
Short-term Investments, Total0.00
Cash & Short-term Investments63.00
Accounts receivable3.34
Income Taxes Receivable, Current NO3.30
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.15
Total Current Assets334.82
Equipment/Property/Plant Net0.06
Long-term investments192.25
Other Assets, Noncurrent260.11
Total Assets527.21
Liabilities
Accounts Payable, Current AC1.27
Accrued Liabilities, Current AC3.16
Other Liabilities, Current8.07
Total Current Liabilities12.50
Long-term debt34.74
Total Long-term Debt34.74
Other liabilities, Noncurrent5.76
Accrued Expenses And Other Current Liabilities9.79
Total Liabilities53.00
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,175.10
Retained Earnings / Accumulated Deficit-694.87
Accumulated Other Comprehensive Income-6.04
Defined Benefit Plan and Other85.75
Other Equity-6.04
Common Stockholder's Equity474.21
Total Stockholder's Equity474.21
Liabilities & Stockholder's Equity527.21
4 historic quarters locked

Sign in to unlock the full Altimmune inc balance sheet history.

About Altimmune Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001326190-26-000052

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.